Penn Medicine The 7th Alfred P. Fishman Symposium New Scientific Discoveries and Impact on Patients with Pulmonary Hypertension or Pulmonary Embolism 2025

Penn Medicine The 7th Alfred P. Fishman Symposium New Scientific Discoveries and Impact on Patients with Pulmonary Hypertension or Pulmonary Embolism 2025

 Include: 18 videos + 17 pdfs, size: 6.83 GB

Target Audience: internists, pulmonologists, cardiologists, critical care physicians

Information:

The Alfred P. Fishman Symposium will present cutting-edge topics pertinent to various types of pulmonary vascular disease. Major advances in research and understanding of the pathobiology and physiology in different types of pulmonary hypertension have translated into novel treatments for patients and a new way of looking at what constitutes successful treatment. Evolving treatment paradigms require a re-evaluation of clinical trial designs which are focused on patient well-being.

1. Review how recent scientific discoveries in pulmonary hypertension can directly translate to improved patient outcomes
2. Discuss the different types of pulmonary hypertension and the appropriate treatment for each.
3. Describe the approach to risk stratification and choice of therapies or referral for lung transplantation
4. Review the new standard of care in treatment of pulmonary embolism and follow-up
5. Discuss novel and alternative approaches to studying treatments in patients with pulmonary hypertension

The 7th Alfred P. Fishman Symposium: New Scientific Discoveries and Impact on Patients with Pulmonary Hypertension or Pulmonary Embolism (2025) is designed for physicians and healthcare professionals specializing in pulmonary vascular diseases.

This symposium is particularly beneficial for:

• Internal Medicine Physicians managing pulmonary hypertension and embolism.
• Pulmonologists & Pediatric Pulmonologists focusing on advanced treatment strategies.
• Cardiologists involved in cardiovascular aspects of pulmonary vascular disease.
• Critical Care Physicians overseeing high-risk pulmonary cases.
• Researchers & Clinicians interested in novel therapies and evolving treatment paradigms.

The event will cover cutting-edge research, risk stratification, treatment approaches, and emerging therapies for pulmonary hypertension and embolism.

 Topics:

• BPA.mp4
• BPA.pdf
• Comorbidities, Inclusion Criteria, and Treatment Effects – More or Less.pdf
• Connect the Tissue Disease Dots in Pulmonary Hypertension.mp4
• Connect the Tissue Disease Dots in Pulmonary Hypertension.pdf
• Data Safety and Monitoring in PAH.mp4
• Data Safety and Monitoring in PAH.pdf
• Hospitalized patient with PAH or IPAH- The Lung Phenotype.mp4
• Hospitalized patient with PAH or IPAH- The Lung Phenotype.pdf
• Magic 8-Ball Says the Patient Has HFpEF PH.mp4
• Magic 8-Ball Says the Patient Has HFpEF PH.pdf
• Minimizing Health Care-Research Contact Days- No place like home.mp4
• Minimizing Health Care-Research Contact Days- No place like home.pdf
• PE(nn) Wars- Debate.mp4
• PE(nn) Wars- Debate.pdf
• People Living with Pulmonary Arterial Hypertension – In Their Own Words.mp4
• Recruiting Minority Members into PH Clinical Trials-Why and how-.mp4
• Recruiting Minority Members into PH Clinical Trials-Why and how-.pdf
• Sex Healing in PAH.mp4
• Sex Healing in PAH.pdf
• Slow Metabolism- The Right Ventricle in Pulmonary Hypertension.mp4
• Slow Metabolism- The Right Ventricle in Pulmonary Hypertension.pdf
• Talking to People who (may) Have a New Diagnosis of Pulmonary Hypertension.mp4
• Talking to People who (may) Have a New Diagnosis of Pulmonary Hypertension.pdf
• The Science Leading to Sotatercept and Beyond.mp4
• The Science Leading to Sotatercept and Beyond.pdf
• To Transplant, or not to Transplant.mp4
• To Transplant, or not to Transplant.pdf
• Treatment of ILD-PH – When to Hold `em and When to Fold `em.mp4
• Treatment of ILD-PH – When to Hold `em and When to Fold `em.pdf
• Welcome & Introduction.mp4
• What’s the (End) Point-.mp4
• What’s the (End) Point-.pdf
• WSPH Treatment Algo in Pulmonary Hypertension.mp4
• WSPH Treatment Algo in Pulmonary Hypertension.pdf